Reaction
Vitreous Opacities reporting signals
As of the last recalculation, Vitreous Opacities appears in 830 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 184.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 180 | 184.5 | 185.5 |
| Faricimab | 40 | 130.0 | 130.6 |
| Ranibizumab | 83 | 87.0 | 87.3 |
| Prednisolone Acetate | 15 | 37.0 | 37.1 |
| Moxifloxacin Hydrochloride | 26 | 33.2 | 33.2 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 24 | 26.4 | 26.5 |
| Triamcinolone Acetonide | 27 | 22.6 | 22.6 |
| Dorzolamide Hydrochloride And Timolol Maleate | 7 | 22.4 | 22.4 |
| Moxifloxacin | 12 | 21.7 | 21.7 |
| Brinzolamide | 6 | 17.4 | 17.5 |
| Brimonidine Tartrate | 8 | 11.4 | 11.4 |